Latest Strategic Transactions News

Aussie Broadband reported a 9% revenue increase to $1.3 billion and a 20% rise in underlying EBITDA for FY26, driven by organic growth and transformative acquisitions including AGL Telco and Nexgen.

Australis Oil & Gas Ltd posted a $2.6 million net loss for 1H 2026 amid sharply reduced production volumes but is progressing its Tuscaloosa Marine Shale development with a key partner and a planned Q4 well spud.

IRIS Metals has appointed Simon Iacopetta as Strategic Advisor and promoted Chris Evans to Executive Chairman, signalling a sharpened focus on expanding its critical minerals portfolio in North America.

ARC Funds Limited has established a $5 million Capital Placement Facility with Securities Vault, giving it flexible access to standby equity capital over 12 months without immediate dilution.

Prestal Holdings Limited (ASX: PTL) has voluntarily suspended trading in its shares pending disclosure of a significant transaction. Details remain under wraps as the company complies with ASX requirements.

Quinbrook Asset Management has lodged a review application challenging a recent Takeovers Panel decision involving Kingsland Minerals. The Panel President has approved the application, but no review Panel has been formed yet.

Yari Resources has outlined a bold strategy to expand its Rolleston South coal project into a district-scale powerhouse, aiming to build over 500 million tonnes of coal resources through acquisitions and joint ventures.

Alicanto Minerals has struck strategic earn-in agreements for its Swedish projects potentially worth A$21 million, while expanding its Mt Henry Gold Project footprint in Western Australia and proposing a name change to Sinclair Gold.

Vectus Biosystems appoints Dr Tara Speranza as CEO and CTO to accelerate development of lead fibrosis drug VB0004 with performance-linked incentives.

The Hydration Pharmaceuticals Company Limited (ASX: HPC) has had its trading suspension lifted as of 4 May 2026, following the lodgement of its delayed Annual Report revealing a $2.86 million net loss.

The Hydration Pharmaceuticals Company Limited (ASX: HPC) temporarily halted trading to relodge its FY25 Annual Report, revealing a $2.86 million loss driven by US market rationalisation and ongoing cost-cutting.

Alchemy Resources secured a major milestone with Newcam Minerals exercising its option on Bryah Iron Ore assets, while divesting Karonie and Lake Rebecca projects to Forrestania Resources, alongside promising exploration results at Yellow Mountain in NSW.